craft-sa-dev Home  

PMC:1626108 / 14844-15213 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T11672 0-1 -LRB- denotes (
T11673 1-2 LS denotes C
T11675 2-3 -RRB- denotes )
T11676 4-7 NN denotes HKI
T11677 8-12 NN denotes rate
T11678 13-15 VBZ denotes is
T11674 16-23 VBN denotes plotted
T11679 24-26 IN denotes as
T11680 27-28 DT denotes a
T11681 29-37 NN denotes function
T11682 38-40 IN denotes of
T11683 41-43 NN denotes LD
T11684 44-57 NN denotes concentration
T11685 58-60 IN denotes at
T11686 61-71 VBG denotes saturating
T11687 72-79 NN denotes glucose
T11689 80-83 CC denotes and
T11690 84-89 VBN denotes fixed
T11691 90-95 NN denotes Cox11
T11692 96-97 -LRB- denotes (
T11694 97-100 CD denotes 7.5
T11693 101-103 NNS denotes nM
T11695 103-104 -RRB- denotes )
T11688 105-119 NNS denotes concentrations
T11696 119-120 . denotes .
T11697 120-225 sentence denotes Note that increasing concentrations of the LD of RanBP2 reverse the inhibition of HKI activity by Cox11.
T11698 121-125 VB denotes Note
T11699 126-130 IN denotes that
T11701 131-141 VBG denotes increasing
T11702 142-156 NNS denotes concentrations
T11703 157-159 IN denotes of
T11704 160-163 DT denotes the
T11705 164-166 NN denotes LD
T11706 167-169 IN denotes of
T11707 170-176 NN denotes RanBP2
T11700 177-184 VBP denotes reverse
T11708 185-188 DT denotes the
T11709 189-199 NN denotes inhibition
T11710 200-202 IN denotes of
T11711 203-206 NN denotes HKI
T11712 207-215 NN denotes activity
T11713 216-218 IN denotes by
T11714 219-224 NN denotes Cox11
T11715 224-225 . denotes .
T11716 225-369 sentence denotes A half-maximal effect of the LD of RanBP2 on HKI activity in the presence of 7.5 nM of Cox11 was observed at a concentration of ~0.05 nM of LD.
T11717 226-227 DT denotes A
T11719 228-232 RB denotes half
T11721 232-233 HYPH denotes -
T11720 233-240 JJ denotes maximal
T11718 241-247 NN denotes effect
T11723 248-250 IN denotes of
T11724 251-254 DT denotes the
T11725 255-257 NN denotes LD
T11726 258-260 IN denotes of
T11727 261-267 NN denotes RanBP2
T11728 268-270 IN denotes on
T11729 271-274 NN denotes HKI
T11730 275-283 NN denotes activity
T11731 284-286 IN denotes in
T11732 287-290 DT denotes the
T11733 291-299 NN denotes presence
T11734 300-302 IN denotes of
T11735 303-306 CD denotes 7.5
T11736 307-309 NNS denotes nM
T11737 310-312 IN denotes of
T11738 313-318 NN denotes Cox11
T11739 319-322 VBD denotes was
T11722 323-331 VBN denotes observed
T11740 332-334 IN denotes at
T11741 335-336 DT denotes a
T11742 337-350 NN denotes concentration
T11743 351-353 IN denotes of
T11744 354-355 SYM denotes ~
T11745 355-359 CD denotes 0.05
T11746 360-362 NNS denotes nM
T11747 363-365 IN denotes of
T11748 366-368 NN denotes LD
T11749 368-369 . denotes .
R7835 T11672 T11673 punct (,C
R7836 T11673 T11674 meta C,plotted
R7837 T11675 T11673 punct ),C
R7838 T11676 T11677 compound HKI,rate
R7839 T11677 T11674 nsubjpass rate,plotted
R7840 T11678 T11674 auxpass is,plotted
R7841 T11679 T11674 prep as,plotted
R7842 T11680 T11681 det a,function
R7843 T11681 T11679 pobj function,as
R7844 T11682 T11681 prep of,function
R7845 T11683 T11684 compound LD,concentration
R7846 T11684 T11682 pobj concentration,of
R7847 T11685 T11674 prep at,plotted
R7848 T11686 T11687 amod saturating,glucose
R7849 T11687 T11688 nmod glucose,concentrations
R7850 T11688 T11685 pobj concentrations,at
R7851 T11689 T11687 cc and,glucose
R7852 T11690 T11691 amod fixed,Cox11
R7853 T11691 T11687 conj Cox11,glucose
R7854 T11692 T11693 punct (,nM
R7855 T11693 T11691 parataxis nM,Cox11
R7856 T11694 T11693 nummod 7.5,nM
R7857 T11695 T11693 punct ),nM
R7858 T11696 T11674 punct .,plotted
R7859 T11699 T11700 mark that,reverse
R7860 T11700 T11698 ccomp reverse,Note
R7861 T11701 T11702 amod increasing,concentrations
R7862 T11702 T11700 nsubj concentrations,reverse
R7863 T11703 T11702 prep of,concentrations
R7864 T11704 T11705 det the,LD
R7865 T11705 T11703 pobj LD,of
R7866 T11706 T11705 prep of,LD
R7867 T11707 T11706 pobj RanBP2,of
R7868 T11708 T11709 det the,inhibition
R7869 T11709 T11700 dobj inhibition,reverse
R7870 T11710 T11709 prep of,inhibition
R7871 T11711 T11712 compound HKI,activity
R7872 T11712 T11710 pobj activity,of
R7873 T11713 T11709 prep by,inhibition
R7874 T11714 T11713 pobj Cox11,by
R7875 T11715 T11698 punct .,Note
R7876 T11717 T11718 det A,effect
R7877 T11718 T11722 nsubjpass effect,observed
R7878 T11719 T11720 advmod half,maximal
R7879 T11720 T11718 amod maximal,effect
R7880 T11721 T11720 punct -,maximal
R7881 T11723 T11718 prep of,effect
R7882 T11724 T11725 det the,LD
R7883 T11725 T11723 pobj LD,of
R7884 T11726 T11725 prep of,LD
R7885 T11727 T11726 pobj RanBP2,of
R7886 T11728 T11718 prep on,effect
R7887 T11729 T11730 compound HKI,activity
R7888 T11730 T11728 pobj activity,on
R7889 T11731 T11718 prep in,effect
R7890 T11732 T11733 det the,presence
R7891 T11733 T11731 pobj presence,in
R7892 T11734 T11733 prep of,presence
R7893 T11735 T11736 nummod 7.5,nM
R7894 T11736 T11734 pobj nM,of
R7895 T11737 T11736 prep of,nM
R7896 T11738 T11737 pobj Cox11,of
R7897 T11739 T11722 auxpass was,observed
R7898 T11740 T11722 prep at,observed
R7899 T11741 T11742 det a,concentration
R7900 T11742 T11740 pobj concentration,at
R7901 T11743 T11742 prep of,concentration
R7902 T11744 T11745 punct ~,0.05
R7903 T11745 T11746 nummod 0.05,nM
R7904 T11746 T11743 pobj nM,of
R7905 T11747 T11746 prep of,nM
R7906 T11748 T11747 pobj LD,of
R7907 T11749 T11722 punct .,observed